In this section, you can find additional resources to help you and your patients stay up-to-date with current developments in the management of Philadelphia chromosome positive (Ph+) chronic myeloid Leukemia (CML).
These include patient education and guidelines and recommendations from the National Comprehensive Cancer Network (NCCN) and European LeukemiaNet (ELN).
Next: For Physicians
Note: Before prescribing, please read full European Summary of Product Characteristics.
|
